Regenxbio (RGNX) Current Assets (2016 - 2025)
Historic Current Assets for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to $332.0 million.
- Regenxbio's Current Assets rose 592.57% to $332.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $332.0 million, marking a year-over-year increase of 592.57%. This contributed to the annual value of $278.0 million for FY2024, which is 1700.74% down from last year.
- Latest data reveals that Regenxbio reported Current Assets of $332.0 million as of Q3 2025, which was up 592.57% from $373.8 million recorded in Q2 2025.
- In the past 5 years, Regenxbio's Current Assets ranged from a high of $518.8 million in Q4 2021 and a low of $278.0 million during Q4 2024
- Its 5-year average for Current Assets is $392.2 million, with a median of $389.2 million in 2023.
- As far as peak fluctuations go, Regenxbio's Current Assets soared by 4742.44% in 2021, and later crashed by 2078.33% in 2025.
- Regenxbio's Current Assets (Quarter) stood at $518.8 million in 2021, then decreased by 19.82% to $416.0 million in 2022, then dropped by 19.47% to $335.0 million in 2023, then decreased by 17.01% to $278.0 million in 2024, then increased by 19.41% to $332.0 million in 2025.
- Its Current Assets stands at $332.0 million for Q3 2025, versus $373.8 million for Q2 2025 and $313.2 million for Q1 2025.